ABSTRACT
Diabetics develop chronic, sight-threatening retinopathy. Retinal blood vessel injuries blind. To determine its clinical profile and link to hypertension, dyslipidemia, and nephropathy, all type 2 diabetics have their fundus tested for proliferative diabetic retinopathy. Cross-sectional. Karad’s Krishna Hospital offers ophthalmology. 2019–2021. Our OPD requires pre-registration. Proliferative diabetic retinopathy patients also had hypertension, dyslipidemia, and nephropathy examined. Assessed. Proliferative diabetic retinopathy data evaluated hypertension, dyslipidemia, and diabetic nephropathy. 44 people were studied from December 2019–May 2021. Excel data Qualitative percentages were mean +/- SD. (min-max). Matches. Chi-square tests compared qualitative variables. An independent student t test evaluated quantitative data between groups when appropriate. Significant. Analyzed open epi 2.3.1 data. Non-compliant 56-year-olds 9.98. Noncompliance. 70% had abnormal cholesterol. PDR was 98% triglycerides. 66% HDL. Benefit less. HDL/LDL. 62% had hypertension. HTN lasted 5–6 years; PDR began sooner. Surveys should detect diabetes and lower risk factors. Diabetics need early retinopathy screening. Counseling non-adherents minimizes sickness.
